Our aim was to assess the effects of the cholesteryl ester transfer protein ( CETP ) inhibitor anacetrapib and atorvastatin , both as monotherapy and in combination , on particle concentrations of low-density lipoproteins ( LDL ) , very low-density lipoproteins ( VLDL ) , and intermediate-density lipoproteins in dyslipidemic patients .